Literature DB >> 10746687

Uterine myxoid leiomyosarcoma within a leiomyoma.

K Mittal1, D Popiolek, R I Demopoulos.   

Abstract

A case of myxoid leiomyosarcoma of the uterus arising in a leiomyoma is reported. Although the tumor showed very low mitotic activity ranging from zero to 2/10 HPF, the presence of infiltrative pattern of growth and a high MIB-1 index (60% of cells positive) established the diagnosis. Myxoid leiomyosarcoma may arise in leiomyoma.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10746687     DOI： 10.1016/s0046-8177(00)80258-0

Source DB:  PubMed          Journal:  Hum Pathol        ISSN： 0046-8177            Impact factor:   3.466


  4 in total

1.  Fibromyxoid variant of endometrial stromal sarcoma with atypical bizarre nuclei.

Authors:  Hyun-Soo Kim; Gun Yoon; Yoon Yang Jung; Yoo-Young Lee; Sang Yong Song
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  Uterine smooth muscle tumors of uncertain malignant potential (STUMP): pathology, follow-up and recurrence.

Authors:  Andrea Dall'Asta; Salvatore Gizzo; Andrea Musarò; Michela Quaranta; Marco Noventa; Costanza Migliavacca; Giulio Sozzi; Michela Monica; Daniele Mautone; Roberto Berretta
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 3.  Uterine myxoid leiomyosarcoma - a rare malignant tumor: the role of complex morphopathological assay. Review and case presentation.

Authors:  Anca Maria Istrate-Ofiţeru; George Lucian Zorilă; Dan Ruican; Ana Maria Petrescu; Elena Iuliana Anamaria Berbecaru; Gabriela Camelia Roşu; Răzvan Grigoraş Căpitănescu; Rodica Daniela Nagy; Liliana Cercelaru; Antonie Edu; Dominic Gabriel Iliescu; Roxana Cristina Drăguşin
Journal:  Rom J Morphol Embryol       Date:  2021 Oct-Dec       Impact factor: 0.833

4.  MED12 alterations in both human benign and malignant uterine soft tissue tumors.

Authors:  Gaëlle Pérot; Sabrina Croce; Agnès Ribeiro; Pauline Lagarde; Valérie Velasco; Agnès Neuville; Jean-Michel Coindre; Eberhard Stoeckle; Anne Floquet; Gaëtan MacGrogan; Frédéric Chibon
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.